Wording of the Statement by the DFG Senate Commissions
Biomaterial banks are an indispensable resource for biomedical research; coordinated, quality-assured and sustainable biomaterial banking is a long-term scientific structural objective, which is essential to the quality and competitiveness of German research. Therefore, it is important for Germany that clear strategies and recommendations for biobanks exist. The DFG, as a substantial funder of biomedical research, is taking an active part in discussions on the future structure of biobanking in Germany and on the regulations that are relevant to it.
1. The DFG Senate Commission on Clinical Research and the DFG Senate Commission on Genetic Research expressly welcome the statement by the German Ethics Council "Human Biobanks for Research". On many issues it represents the "gold standard" for biomaterial banks and is a suitable approach for placing research biomaterial banks on a sustainable and coordinated basis in the long term that is accepted by all stakeholders.
2. Already, large existing and planned biomaterial banks can fulfil the requirements of the German Ethics Council without legal regulation (for example National Cohort, PopGen , tissue bank of the Nationales Centrum fr Tumorerkrankungen (National Centre for Tumour Diseases, NCT) , tissue banks of the Network of Comprehensive Cancer Centres). In principle however, these requirements place a considerable, not to mention financial, constraint on the biomaterial banks, which has not been adequately represented in the available structural funding up to now.
3. For many relevant biomaterial banks which do not have the necessary resources at their disposal, the formal requirements in the statement by the German Ethics Council are very high and thereby threaten their continued existence. On the other hand, in the interests of all stakeholders the do
|Contact: Dr. Eva-Maria Streier|